The discovery and validation of new drug targets in cancer
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 9 (6) , 632-636
- https://doi.org/10.1016/s0958-1669(98)80142-0
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancersThe EMBO Journal, 1998
- Antiangiogenic tumour therapy: will it work?Trends in Pharmacological Sciences, 1998
- Mutations of mitotic checkpoint genes in human cancersNature, 1998
- Cell Division Gatekeepers IdentifiedScience, 1998
- Malignant Transformation of Mammalian Cells Initiated by Constitutive Expression of thePolo-like Kinase1Biochemical and Biophysical Research Communications, 1997
- Kinetochore Localization of Murine Bub1 Is Required for Normal Mitotic Timing and Checkpoint Response to Spindle DamageCell, 1997
- Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes.The Journal of cell biology, 1996
- Purification and Molecular Cloning of Plx1, a Cdc25-Regulatory Kinase from Xenopus Egg ExtractsScience, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase.Molecular and Cellular Biology, 1994